amlexanox has been researched along with Contact Dermatitis in 3 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayakawa, R | 1 |
Ogino, Y | 1 |
Aris, K | 1 |
Matsunaga, K | 1 |
Kabasawa, Y | 1 |
Kanzaki, T | 1 |
Yamashita, H | 1 |
Kawashima, M | 1 |
3 other studies available for amlexanox and Contact Dermatitis
Article | Year |
---|---|
Systemic contact dermatitis due to amlexanox.
Topics: Adult; Aminopyridines; Dermatitis, Contact; Drug Eruptions; Female; Humans; Ophthalmic Solutions | 1992 |
Allergic contact dermatitis from amlexanox (Elics) ophthalmic solution.
Topics: Aged; Aminopyridines; Dermatitis, Contact; Drug Eruptions; Female; Humans; Male; Ophthalmic Solution | 1991 |
Contact dermatitis from amlexanox eyedrops.
Topics: Administration, Topical; Adult; Aminopyridines; Dermatitis, Contact; Drug Eruptions; Eyelids; Facial | 1991 |